Drug Type Small molecule drug |
Synonyms AAGP |
Target |
Mechanism VCAM1 inhibitors(Vascular cell adhesion molecule 1 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC20H35ClF2N4O11 |
InChIKeyYCFCRIHFQHDKJB-UYOVMGBSSA-N |
CAS Registry890015-62-0 |
Start Date17 Feb 2017 |
Sponsor / Collaborator |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Diabetes Mellitus, Type 1 | Phase 2 | - | - | |
Diabetes Mellitus, Type 1 | Phase 2 | - | - | |
Dry Eye Syndromes | Discovery | CA | 06 Apr 2020 | |
Cardiovascular Diseases | Discovery | CA | 22 Sep 2018 |
Study | Phase | Population | Analyzed Enrollment | Group | Results | Evaluation | Publication Date |
---|
No Data |